Guardant Health, Inc. (NASDAQ:GH) Receives $47.71 Consensus Price Target from Analysts

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has received an average rating of “Moderate Buy” from the sixteen ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12 month price target […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Lattice Semiconductor Co. (NASDAQ:LSCC) Target Price at $87.25
Next post Bank of Montreal (TSE:BMO) Receives C$131.42 Average Price Target from Analysts